Safety Of Trasylol Will Be Reviewed By FDA Advisory Panel In September 2007
September 5th, 2007 Posted by: Dr. Cox
Will Consider Data Suggesting Trasylol Can Cause Kidney Damage, Heart Failure, and Death
(Posted by Tom Lamb at DrugInjuryWatch.com)
An August 22, 2007 article, “FDA panel will review Trasylol safety”, published in the TheBoston Globe informed that the FDA will convene an advisory committee of drug safety experts on September 12, 2007 to discuss Bayer AG’s blood-clotting drug Trasylol.